These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 18268402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.
    Kishimoto K, Kaneko S, Ohmori K, Tamura T, Hasegawa K.
    Mediators Inflamm; 2006; 2006(1):42726. PubMed ID: 16864903
    [Abstract] [Full Text] [Related]

  • 4. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
    Senda M, Kubo N, Adachi K, Ikari Y, Matsumoto K, Shimizu K, Tominaga H.
    J Nucl Med; 2009 Jun; 50(6):887-92. PubMed ID: 19443589
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
    Strasser A, Wittmann HJ, Seifert R.
    J Pharmacol Exp Ther; 2008 Sep; 326(3):783-91. PubMed ID: 18577700
    [Abstract] [Full Text] [Related]

  • 7. Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
    Tamura T, Komai M.
    Int Immunopharmacol; 2008 Jun; 8(6):916-21. PubMed ID: 18442798
    [Abstract] [Full Text] [Related]

  • 8. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    Tamura T, Amano T, Ohmori K, Manabe H.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):149-54. PubMed ID: 16259975
    [Abstract] [Full Text] [Related]

  • 9. Roles of Lys191 and Lys179 in regulating thermodynamic binding forces of ligands to determine their binding affinity for human histamine H1 receptors.
    Kobayashi C, Tanaka A, Yasuda T, Hishinuma S.
    Biochem Pharmacol; 2020 Oct 07; 180():114185. PubMed ID: 32738199
    [Abstract] [Full Text] [Related]

  • 10. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
    Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE, Williams SM, Greenfeder S, Billah M, Kreutner W, Egan RE.
    Eur J Pharmacol; 2002 Aug 09; 449(3):229-37. PubMed ID: 12167464
    [Abstract] [Full Text] [Related]

  • 11. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
    Tashiro M, Mochizuki H, Sakurada Y, Ishii K, Oda K, Kimura Y, Sasaki T, Ishiwata K, Yanai K.
    Br J Clin Pharmacol; 2006 Jan 09; 61(1):16-26. PubMed ID: 16390347
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells.
    Moguilevsky N, Varsalona F, Guillaume JP, Noyer M, Gillard M, Daliers J, Henichart JP, Bollen A.
    J Recept Signal Transduct Res; 1995 Jan 09; 15(1-4):91-102. PubMed ID: 8903934
    [Abstract] [Full Text] [Related]

  • 13. Interactions of olopatadine and selected antihistamines with model and natural membranes.
    Brockman HL, Momsen MM, Knudtson JR, Miller ST, Graff G, Yanni JM.
    Ocul Immunol Inflamm; 2003 Dec 09; 11(4):247-68. PubMed ID: 14704897
    [Abstract] [Full Text] [Related]

  • 14. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX, Schalkhausser F, Ye QZ, Seifert R, Buschauer A.
    Arch Pharm (Weinheim); 2007 Jan 09; 340(1):9-16. PubMed ID: 17206612
    [Abstract] [Full Text] [Related]

  • 15. Unique binding pocket for KW-4679 in the histamine H1 receptor.
    Nonaka H, Otaki S, Ohshima E, Kono M, Kase H, Ohta K, Fukui H, Ichimura M.
    Eur J Pharmacol; 1998 Mar 12; 345(1):111-7. PubMed ID: 9593602
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
    Strasser A, Wittmann HJ, Kunze M, Elz S, Seifert R.
    Mol Pharmacol; 2009 Mar 12; 75(3):454-65. PubMed ID: 19047480
    [Abstract] [Full Text] [Related]

  • 17. Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.
    Gillard M, Chatelain P.
    Eur J Pharmacol; 2006 Jan 20; 530(3):205-14. PubMed ID: 16388798
    [Abstract] [Full Text] [Related]

  • 18. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA, Xu SX, Yanni JM.
    J Ocul Pharmacol Ther; 1996 Jan 20; 12(4):401-7. PubMed ID: 8951676
    [Abstract] [Full Text] [Related]

  • 19. Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.
    Hishinuma S, Sugawara K, Uesawa Y, Fukui H, Shoji M.
    Biochem Pharmacol; 2014 Sep 15; 91(2):231-41. PubMed ID: 25065879
    [Abstract] [Full Text] [Related]

  • 20. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX, Kraus A, Ghorai P, Ye QZ, Elz S, Buschauer A, Seifert R.
    J Pharmacol Exp Ther; 2006 Jun 15; 317(3):1262-8. PubMed ID: 16554355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.